Experiences with bortezomib in multiple myeloma - from Phase II studies to daily practice

Int J Clin Pharmacol Ther. 2010 Jul;48(7):494-6. doi: 10.5414/cpp48494.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Clinical Trials, Phase II as Topic
  • Humans
  • Multiple Myeloma / drug therapy*
  • Pyrazines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Pyrazines
  • Bortezomib